The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria.
Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion.
California-based Amgen is barred from succeeding on its patent infringement claim against Coherus Biosciences, according to the US Court of Appeals for the Federal Circuit.
Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.
Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.
Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.
A Kentucky jury has awarded a seed company $2.4 million, after finding that an ex-employee had misappropriated trade secrets related to work on broccoli seeds and sprouts.
Morrison & Foerster has strengthened its life sciences group with the addition of Bethany Hills as a partner in New York.
The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.